1148348

Nader Iskander, M.D. — FEI 3017889750

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 6, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
San Antonio, TX (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance
756221 CFR 312.60Informed consent